These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34434158)

  • 41. Long-term adherence to continuous positive airway pressure therapy in non-sleepy sleep apnea patients.
    Campos-Rodriguez F; Martinez-Alonso M; Sanchez-de-la-Torre M; Barbe F;
    Sleep Med; 2016 Jan; 17():1-6. PubMed ID: 26847966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management.
    Chapman JL; Serinel Y; Marshall NS; Grunstein RR
    Sleep Med Clin; 2016 Sep; 11(3):353-63. PubMed ID: 27542881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view.
    Craig S; Pépin JL; Randerath W; Caussé C; Verbraecken J; Asin J; Barbé F; Bonsignore MR
    Eur Respir Rev; 2022 Jun; 31(164):. PubMed ID: 35613742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol.
    Mineiro MA; Marques da Silva P; Alves M; Virella D; Marques Gomes MJ; Cardoso J
    BMJ Open; 2016 Jul; 6(7):e011385. PubMed ID: 27406645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Risk for sleep apnea syndrome and excessive daily sleepiness in chronic hemodialysis patients].
    Zibar L; Kristić A; Krnjeta D; Dogas Z
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():30-5. PubMed ID: 23120812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Residual subjective daytime sleepiness under CPAP treatment in initially somnolent apnea patients: a pilot study using data mining methods.
    Nguyên XL; Rakotonanahary D; Chaskalovic J; Philippe C; Hausser-Hauw C; Lebeau B; Fleury B
    Sleep Med; 2008 Jul; 9(5):511-6. PubMed ID: 17921054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CPAP adherence of patients with obstructive sleep apnea.
    Salepci B; Caglayan B; Kiral N; Parmaksiz ET; Comert SS; Sarac G; Fidan A; Gungor GA
    Respir Care; 2013 Sep; 58(9):1467-73. PubMed ID: 23431305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. OSA and CPAP therapy: effect of gender, somnolence, and treatment adherence on health-related quality of life.
    Lo Bue A; Salvaggio A; Iacono Isidoro S; Romano S; Insalaco G
    Sleep Breath; 2020 Jun; 24(2):533-540. PubMed ID: 31309464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline Lighter Sleep and Lower Saturation Are Associated With Improved Sleepiness and Adherence on Continuous Rather Than Autotitrating Positive Airway Pressure.
    Sangal RB; Sudan N
    Clin EEG Neurosci; 2020 May; 51(3):174-179. PubMed ID: 31852280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationships between improvements in daytime sleepiness, fatigue and depression and psychomotor vigilance task testing with CPAP use in patients with obstructive sleep apnea.
    Bhat S; Gupta D; Akel O; Polos PG; DeBari VA; Akhtar S; McIntyre A; Ming SX; Upadhyay H; Chokroverty S
    Sleep Med; 2018 Sep; 49():81-89. PubMed ID: 30093261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, polysomnographic, and CPAP titration features of obstructive sleep apnea: Mixed versus purely obstructive type.
    Lee SA; Lee GH; Chung YS; Kim WS
    J Neurol Sci; 2015 Aug; 355(1-2):150-4. PubMed ID: 26066559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obstructive sleep apnea and self-reported functional impairment in revascularized patients with coronary artery disease in the RICCADSA trial.
    Baniak LM; Chasens ER; Luyster FS; Strollo PJ; Thunström E; Peker Y
    Sleep Breath; 2018 Dec; 22(4):1169-1177. PubMed ID: 30324547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating sleep apnea in Parkinson's disease with C-PAP: feasibility concerns and effects on cognition and alertness.
    Terzaghi M; Spelta L; Minafra B; Rustioni V; Zangaglia R; Pacchetti C; Manni R
    Sleep Med; 2017 May; 33():114-118. PubMed ID: 28449889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: Contribution of daytime sleepiness to residual depressive symptoms.
    Habukawa M; Uchimura N; Kakuma T; Yamamoto K; Ogi K; Hiejima H; Tomimatsu K; Matsuyama S
    Sleep Med; 2010 Jun; 11(6):552-7. PubMed ID: 20488748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The estimation of excessive daytime sleepiness in post-stroke patients - a polysomnographic study.
    Martynowicz H; Jodkowska A; Skomro R; Gać P; Brylka A; Bladowski M; Wojakowska A; Mazur G; Poręba R
    Respir Physiol Neurobiol; 2019 Sep; 267():1-5. PubMed ID: 31136826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Features and Contributing Factors of Excessive Daytime Sleepiness in Chinese Obstructive Sleep Apnea Patients: The Role of Comorbid Symptoms and Polysomnographic Variables.
    Shao C; Qi H; Lang R; Yu B; Tang Y; Zhang L; Wang X; Wang L
    Can Respir J; 2019; 2019():5476372. PubMed ID: 31360269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-response relationship between positive airway pressure therapy and excessive daytime sleepiness: the HomePAP study.
    Pascoe M; Bena J; Andrews ND; Auckley D; Benca R; Billings ME; Kapur VK; Iber C; Zee PC; Redline S; Rosen CL; Foldvary-Schaefer N
    J Clin Sleep Med; 2022 Apr; 18(4):1027-1034. PubMed ID: 34870587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of obstructive sleep apnea and daytime sleepiness on work limitation.
    Mulgrew AT; Ryan CF; Fleetham JA; Cheema R; Fox N; Koehoorn M; Fitzgerald JM; Marra C; Ayas NT
    Sleep Med; 2007 Dec; 9(1):42-53. PubMed ID: 17825611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.